The trial assessed the efficacy and safety of Reblozyl compared to epoetin alfa, an erythropoiesis-stimulating agent, in treating anaemia due to MDS. It included subjects who needed red blood cell ...
24 hr Prescribing information Epoetin alfa multidose Procrit (Ortho Biotech) 7 days Manufacturer Epoetin alfa single dose Procrit (Ortho Biotech) 14 days Manufacturer Eptifibatide 2 mg/mL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback